Jim Cramer: Experts are calling Vertex Pharmaceuticals the 'most promising story in biotech'

"As much as I hate to chase, I honestly don't think you're that late to the party with Vertex if you buy it at these levels," the "Mad Money" host says.

For access to live and exclusive video from CNBC subscribe to CNBC PRO:

» Subscribe to CNBC TV:
» Subscribe to CNBC:
» Subscribe to CNBC Classic:

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

Connect with CNBC News Online
Get the latest news:
Follow CNBC on LinkedIn:
Follow CNBC News on Facebook:
Follow CNBC News on Twitter:
Follow CNBC News on Instagram:

#CNBC
#CNBC TV

CNBC,Mad Money,invest,investing,stock market,jim cramer,cramer,kramer,wall street,lightning round,investment strategy,retirement,